Several companies across disparate sectors began marketing their planned initial public offerings on Monday, signaling that a subset of issuers is prepared to proceed with public listings even as markets contend with geopolitical uncertainty tied to the Middle East conflict.
Among the firms that disclosed terms or kicked off roadshows were convenience store operator Yesway nL4N40W0YD, proteomics business Alamar Biosciences, obesity drug developer Kailera Therapeutics nL4N40W0NV and real estate investment trust National Healthcare Properties nL4N40W0QQ. These launches came as market participants weigh the outlook for volatility and investor demand ahead of potential listings.
“It speaks to the volume of pre-IPO companies waiting on the sidelines. A number of issuers just need to see some sign of stability and they’ll launch their offerings,” said Matt Kennedy, senior strategist at Renaissance Capital, which tracks IPO activity and provides related ETFs. The comment underscored that there is a pipeline of candidate listings that have been deferring market entry pending clearer conditions.
Market sentiment has shown some easing in recent sessions. The VIX Volatility Index, a commonly used measure of market fear, moved below 20 last week for the first time in over a month - a threshold some investors interpret as a sign of calmer conditions. That decline coincides with renewed attempts by certain issuers to engage prospective investors directly through roadshows.
Optimism among IPO observers has not vanished. Lukas Muehlbauer, an associate at IPOX Research, said the year remains on pace for a meaningful rebound in offerings: “2026 is still on track to be the best year for IPOs since the post-pandemic drought, and it may even get there without the mega listings. Disciplined pricing and attractive valuations make this a ’buyer’s market’, giving those deals a stronger chance of trading well after listing.”
The near-term pipeline received a boost after six companies from sectors ranging from defense nL4N40T0XH to REIT nL4N40T1JE publicly filed for IPOs on Friday, adding to the roster of potential listings that investors and underwriters are monitoring.
Nonetheless, uncertainty has not been fully resolved. Weekend diplomatic talks between the U.S. and Iran failed to produce an agreement to end the conflict, a development that leaves geopolitical risk as a continuing variable for both markets and issuers. Separately, investor-focused presentations also resumed for high-profile vehicles: Bill Ackman’s Pershing Square initiated a roadshow nL4N40W0RT for the U.S. IPOs of his management company and a new fund.
For issuers contemplating entry to public markets, the current environment presents a mix of opportunity and caution. Market participants say that if volatility remains subdued and valuations stay attractive, the pipeline of pre-IPO companies could translate into a steady cadence of listings in the months ahead. If instability returns, however, some issuers may yet choose to delay or adjust terms.
Market context and near-term outlook: A cluster of roadshows and filings suggests supply is ready to move once conditions look stable; VIX readings below 20 and disciplined deal pricing are cited as supportive factors. Geopolitical risk and episodic volatility remain the main variables that could affect timing and reception of upcoming offerings.